Skip to menu Skip to content Skip to footer

2026

Journal Article

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer

Zeng, Zhen, Gandini, Anastasia, Bhatt, Rituparna, Proctor, Martina, Goh, Nicole-Lisa Li-Ann, Vora, Shivam, Walsh, Thomas P., Wu, Sherry Y., Ferguson, Kaltin, Coward, Jermaine I., Kumari, Snehlata, Haass, Nikolas K., Wells, James W., Hardy, Janet, Perrin, Lewis, He, Yaowu, Hooper, John D., Ho, Gwo-Yaw, Gonzalez Cruz, Jazmina L. and Gabrielli, Brian (2026). Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer. British Journal of Cancer, 1-11. doi: 10.1038/s41416-026-03416-y

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer

2025

Journal Article

Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells

Vora, Shivam, Chatterjee, Saptarshi, Andrew, Ariel, Kumar, Ramyashree Prasanna, Proctor, Martina, Zeng, Zhen, Bhatt, Rituparna, Nazareth, Deborah, Fernando, Madushan, Jones, Mathew J. K., He, Yaowu, Hooper, John D., McMillan, Nigel A. J., Urosevic, Jelena, Saeh, Jamal, Travers, Jon, Cimini, Daniela, Chen, Jing and Gabrielli, Brian (2025). Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells. Cell Death and Disease, 16 (1) 7, 1-11. doi: 10.1038/s41419-024-07329-7

Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells

2018

Journal Article

The role of CXCR3 and its chemokine ligands in skin disease and cancer

Kuo, Paula T., Zeng, Zhen, Salim, Nazhifah, Mattarollo, Stephen, Wells, James W. and Leggatt, Graham R. (2018). The role of CXCR3 and its chemokine ligands in skin disease and cancer. Frontiers in Medicine, 5 (SEP) 271, 271. doi: 10.3389/fmed.2018.00271

The role of CXCR3 and its chemokine ligands in skin disease and cancer